STACY WILLIAMS: Open Payments
NPI 1629031984 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,207 in 116 payments from 15 companies in 2025. Trend: 2023 $2,428 · 2024 $1,397 · 2025 $2,207
Food & beverage: $2,207
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $354 |
| ABBVIE INC. | 16 | $275 |
| Janssen Biotech, Inc. | 13 | $253 |
| Incyte Corporation | 16 | $243 |
| Lilly USA, LLC | 17 | $235 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $198 |
| Galderma Laboratories, L.P. | 12 | $152 |
| LEO Pharma Inc. | 8 | $137 |
| Arcutis Biotherapeutics, Inc. | 5 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
Products named: DUPIXENT, TREMFYA, OPZELURA, TALTZ, Winlevi, SKYRIZI, NEMLUVIO, ADBRY.
Industry payments across CA — which companies pay providers there.
